JB Chemicals & Pharmaceuticals has successfully completed the acquisition of the brand 'Azmarda' from Novartis AG, Switzerland. Azmarda indicated for heart failure patients with reduced ejection fraction (HfrEF).
JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).